Clinical Gastroenterology and Hepatology
Volume 8, Issue 2 , Pages 143-150 , February 2010

Algorithms Outperform Metabolite Tests in Predicting Response of Patients With Inflammatory Bowel Disease to Thiopurines

  • Akbar K. Waljee

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
    • ,
  • Joel C. Joyce

      Affiliations

    • General Clinical Research Center, University of Michigan, Ann Arbor, Michigan
    • ,
  • Sijian Wang

      Affiliations

    • Department of Statistics, University of Wisconsin, Madison, Wisconsin
    • ,
  • Aditi Saxena

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
    • ,
  • Margaret Hart

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
    • ,
  • Ji Zhu

      Affiliations

    • Department of Statistics, University of Michigan, Ann Arbor, Michigan
    • ,
  • Peter D.R. Higgins

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan
    • Corresponding Author InformationReprint requests Address requests for reprints to: Peter D. R. Higgins, MD, PhD, MSc, Division of Gastroenterology, University of Michigan, 6520 MSRB I, Box 0682, 1150 West Medical Center Drive, Ann Arbor, Michigan 48109. fax: (734) 763-2535

References 

  1. Cohen RD, Woseth DM, Thisted RA, et al. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis. Am J Gastroenterol. 2000;95:1263–1276
  2. Hanauer SB. The case for using 5-aminosalicyclates in Crohn's disease: pro. Inflamm Bowel Dis. 2005;11:609–612
  3. Domenech E. Inflammatory bowel disease: current therapeutic options. Digestion. 2006;73(Suppl 1):67–76
  4. Lopez-Sanroman A, Bermejo F, Carrera E, et al. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis. Aliment Pharmacol Ther. 2004;20:161–166
  5. Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut. 2006;55:47–53
  6. Dervieux T, Meyer G, Barham R, et al. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy. Clin Chem. 2005;51:2074–2084
  7. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705–713
  8. Osterman MT, Kundu R, Lichtenstein GR, et al. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130:1047–1053
  9. Mayo Medical Laboratories. Prometheus thiopurine metabolites. http://www.mayomedicallaboratories.com/test-catalog/print.php?unit_code=915642008;Accessed: November 1, 2008
  10. Mayer L. When is too much enough?. Gastroenterology. 2006;130:1352–1354
  11. Thomas CW, Lowry PW, Franklin CL, et al. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Inflamm Bowel Dis. 2003;9:237–245
  12. Achkar JP, Hanauer SB. Medical therapy to reduce postoperative Crohn's disease recurrence. Am J Gastroenterol. 2000;95:1139–1146
  13. Dubinsky MC, Yang H, Hassard PV, et al. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 2002;122:904–915
  14. Freund Y, Schapire RE. Experiments with a new boosting algorithm. In:  Saitta L editors. Machine Learning: Proceedings of the Thirteenth International Conference. San Francisco, CA: Morgan Kaufmann Publishers, Inc; 1996;p. 148–156
  15. Friedman J, Popescu B. Predictive learning via rule ensembles. Palo Alto, CA: Stanford University Department of Statistics Technical Report; 2005;
  16. Breiman L. Random forest. Mach Learn. 2001;45:5–32
  17. Pencina MJ, D'Agostino RB, D'Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172207–212
  18. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat. 1996;5:299–314
  19. Bonner GF, Fakhri A, Vennamaneni SR. A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10:751–757
  20. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398–1405

 View this article's video abstract at www.cghjournal.org.

 Conflicts of interest The authors disclose the following: The Regents of the University of Michigan, along with authors Peter Higgins, Akbar Waljee, Joel Joyce, Sijian Wang, and Ji Zhu, have applied for a patent on the application of machine learning to patterns in the complete blood count and differential and the comprehensive chemistry panel to the prediction of clinical response to thiopurines. As of December 20, 2009, no patent has yet been granted. The remaining authors disclose no conflicts.

PII: S1542-3565(09)01011-8

doi: 10.1016/j.cgh.2009.09.031

Clinical Gastroenterology and Hepatology
Volume 8, Issue 2 , Pages 143-150 , February 2010